FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37638911> ?p ?o ?g. }

• Q37638911 description "article científic" @default.
• Q37638911 description "article scientifique" @default.
• Q37638911 description "articolo scientifico" @default.
• Q37638911 description "artigo científico" @default.
• Q37638911 description "artículu científicu espublizáu en 2014" @default.
• Q37638911 description "bilimsel makale" @default.
• Q37638911 description "scientific article published on 22 January 2014" @default.
• Q37638911 description "vedecký článok" @default.
• Q37638911 description "vetenskaplig artikel" @default.
• Q37638911 description "videnskabelig artikel" @default.
• Q37638911 description "vědecký článek" @default.
• Q37638911 description "wetenschappelijk artikel" @default.
• Q37638911 description "wissenschaftlicher Artikel" @default.
• Q37638911 description "наукова стаття, опублікована в січні 2014" @default.
• Q37638911 description "научни чланак" @default.
• Q37638911 description "مقالة علمية نشرت في 22 يناير 2014" @default.
• Q37638911 name "Low-dose angiostatic tyrosine kinase inhibitors improve photodynamic therapy for cancer: lack of vascular normalization" @default.
• Q37638911 name "Low-dose angiostatic tyrosine kinase inhibitors improve photodynamic therapy for cancer: lack of vascular normalization" @default.
• Q37638911 name "Low-dose angiostatic tyrosine kinase inhibitors improve photodynamic therapy for cancer: lack of vascular normalization" @default.
• Q37638911 type Item @default.
• Q37638911 label "Low-dose angiostatic tyrosine kinase inhibitors improve photodynamic therapy for cancer: lack of vascular normalization" @default.
• Q37638911 label "Low-dose angiostatic tyrosine kinase inhibitors improve photodynamic therapy for cancer: lack of vascular normalization" @default.
• Q37638911 label "Low-dose angiostatic tyrosine kinase inhibitors improve photodynamic therapy for cancer: lack of vascular normalization" @default.
• Q37638911 prefLabel "Low-dose angiostatic tyrosine kinase inhibitors improve photodynamic therapy for cancer: lack of vascular normalization" @default.
• Q37638911 prefLabel "Low-dose angiostatic tyrosine kinase inhibitors improve photodynamic therapy for cancer: lack of vascular normalization" @default.
• Q37638911 prefLabel "Low-dose angiostatic tyrosine kinase inhibitors improve photodynamic therapy for cancer: lack of vascular normalization" @default.
• Q37638911 P1104 Q37638911-E31CC450-110B-4D51-BCF4-86F5F8B00B06 @default.
• Q37638911 P1433 Q37638911-80EFB81C-AD38-452D-9237-0A857DB44A1C @default.
• Q37638911 P1476 Q37638911-7DB943E8-D60C-4965-804B-81758C8A9CBD @default.
• Q37638911 P2093 Q37638911-1BD778B2-3D48-40A1-8E6D-C259686C0F4C @default.
• Q37638911 P2093 Q37638911-4A5B30A7-65F1-427C-8E46-18B9A48555B9 @default.
• Q37638911 P2093 Q37638911-C98B0B05-86C0-41D5-B1A6-EEFEE0EC1601 @default.
• Q37638911 P2860 Q37638911-02F9ABBD-BD93-48DF-8817-A198AA77A904 @default.
• Q37638911 P2860 Q37638911-0328BC9D-706F-4096-A285-2E3FF3A0EE87 @default.
• Q37638911 P2860 Q37638911-0C360B5C-B3E0-45BD-AC85-A8052C87FF07 @default.
• Q37638911 P2860 Q37638911-0D36E68D-5E0B-45A7-A276-A1B116008BEC @default.
• Q37638911 P2860 Q37638911-1B3BBAAE-51C3-4378-AD78-B9A07BF34921 @default.
• Q37638911 P2860 Q37638911-27C1A088-920E-4902-AB05-72BDA463534E @default.
• Q37638911 P2860 Q37638911-28378977-07B3-44CC-90D0-0C7BC3EE3A33 @default.
• Q37638911 P2860 Q37638911-2D5F7C0D-2FB3-4499-B681-0105E64250A9 @default.
• Q37638911 P2860 Q37638911-2D644987-0C15-40D3-B103-104772BA4EFD @default.
• Q37638911 P2860 Q37638911-321AAD30-F26B-46A1-8DC6-9B00FDAE91F1 @default.
• Q37638911 P2860 Q37638911-389B89AD-FAC7-4507-BB0A-FEE5E6149802 @default.
• Q37638911 P2860 Q37638911-39E8432A-F792-42DD-8833-F3615EFFF279 @default.
• Q37638911 P2860 Q37638911-3E817848-A130-4E89-AB8F-CDA2718E75CF @default.
• Q37638911 P2860 Q37638911-40E04B86-EA98-47B1-9355-44E9414246F3 @default.
• Q37638911 P2860 Q37638911-40EFBF77-E780-4F7D-9311-0AC267E30C64 @default.
• Q37638911 P2860 Q37638911-412E5E8B-63F7-4858-B68F-367843EEEFD1 @default.
• Q37638911 P2860 Q37638911-42C544D0-D503-45EA-A32F-6CE595EB8F00 @default.
• Q37638911 P2860 Q37638911-51BA21C2-DA69-4595-B1A7-78E9CB318735 @default.
• Q37638911 P2860 Q37638911-5973707E-5A1D-4D15-999D-456E4311AA15 @default.
• Q37638911 P2860 Q37638911-5AEA693F-C733-4C74-BC47-057A35FB01C7 @default.
• Q37638911 P2860 Q37638911-5EAC9EEF-BCEA-40A7-A71D-819AA8A9206E @default.
• Q37638911 P2860 Q37638911-66B8EE82-99F1-453F-AFEF-D5E0000F7731 @default.
• Q37638911 P2860 Q37638911-772F18B5-66C8-4FBB-A66C-21532804D59B @default.
• Q37638911 P2860 Q37638911-78F25467-C409-4247-A960-039520D4D3CB @default.
• Q37638911 P2860 Q37638911-7AAC55A2-C088-4C28-973A-F53BC84DFAC6 @default.
• Q37638911 P2860 Q37638911-80D9D234-6F0E-4FF2-8864-8F343CB3196A @default.
• Q37638911 P2860 Q37638911-842E9938-ECDD-4C6F-94D4-A8796E8F5844 @default.
• Q37638911 P2860 Q37638911-873B829D-D3A5-4B5B-AFB0-1FC8517397FF @default.
• Q37638911 P2860 Q37638911-8BEE397F-7A1F-49A8-A342-1756571BCE1A @default.
• Q37638911 P2860 Q37638911-8BF3BDD9-7DC2-4DDB-BFA4-D6983EB5E2BD @default.
• Q37638911 P2860 Q37638911-922E4A51-34A5-4BE9-85EF-F0F8EE3B5170 @default.
• Q37638911 P2860 Q37638911-989742FE-9677-4C9D-A160-D146119A37B7 @default.
• Q37638911 P2860 Q37638911-A14EEC5B-1DFB-4EC3-A64F-D1BC83D808F9 @default.
• Q37638911 P2860 Q37638911-ACD1970C-F503-43DB-9F98-D38457D941A5 @default.
• Q37638911 P2860 Q37638911-B1556EF6-77D0-4188-94CD-736C8AA74B33 @default.
• Q37638911 P2860 Q37638911-BB3FA0C1-3C0F-474F-95EB-F834B9A23F3E @default.
• Q37638911 P2860 Q37638911-BBA690FC-C70B-4D4B-ABA8-C5D2C417C8F1 @default.
• Q37638911 P2860 Q37638911-D1E87F13-C1FC-4760-87E2-257A75683A8E @default.
• Q37638911 P2860 Q37638911-D23E1E32-D871-478E-8462-D070CCEBF482 @default.
• Q37638911 P2860 Q37638911-D3868D4F-40BB-46D9-AFF5-873CCE7B3F72 @default.
• Q37638911 P2860 Q37638911-DAC35145-D869-4793-9D30-3F0B3EAE939B @default.
• Q37638911 P2860 Q37638911-E989A797-C11E-4ED5-A051-7F13F21AF934 @default.
• Q37638911 P2860 Q37638911-EE521857-9B4F-478B-A775-EBDEA16EAB3B @default.
• Q37638911 P2860 Q37638911-F108659E-8B93-4973-BAE4-C1EE26BD00B0 @default.
• Q37638911 P2860 Q37638911-FD064B71-1EE7-45DC-A9D7-B86824582FB0 @default.
• Q37638911 P304 Q37638911-43180476-84C6-4F21-99A8-5EDC93F1E585 @default.
• Q37638911 P31 Q37638911-F5838D4A-F167-4D57-954E-26B113C00DD8 @default.
• Q37638911 P356 Q37638911-1657B2FB-96E9-4F09-8983-311A615539F8 @default.
• Q37638911 P433 Q37638911-4F69D9C7-6DCC-4E06-A30A-8472061CFC92 @default.
• Q37638911 P4510 Q37638911-CBB828F5-A5AC-4551-A9DC-D834684E3B23 @default.
• Q37638911 P478 Q37638911-22D54906-7F75-476B-BB68-A577CA27E4CE @default.
• Q37638911 P50 Q37638911-2C1185CF-1EEA-46D0-8335-E9DB8F311E9D @default.
• Q37638911 P50 Q37638911-4633EF3A-C1F2-415D-A11A-FE3F7CB00CB8 @default.
• Q37638911 P50 Q37638911-69DF345B-EEDD-4419-A756-E7020FFD93C4 @default.
• Q37638911 P50 Q37638911-DCFCC1A7-69AE-4CC8-9664-82CB86364051 @default.
• Q37638911 P577 Q37638911-F4C64720-D9D4-4460-ACAF-3D062387174C @default.
• Q37638911 P5875 Q37638911-A9FA37AA-8B91-41CC-9EAA-E13BA733182C @default.
• Q37638911 P698 Q37638911-9791E49F-62B6-415C-87B9-A407F412785D @default.
• Q37638911 P8608 Q37638911-AD126D4C-0636-47F8-A927-C5D0D40A73C1 @default.
• Q37638911 P932 Q37638911-12A0D848-150A-45D2-A865-972E0ECEE82A @default.
• Q37638911 P356 JCMM.12199 @default.
• Q37638911 P698 24450440 @default.
• Q37638911 P1104 "+12" @default.
• Q37638911 P1433 Q1524063 @default.
• Q37638911 P1476 "Low-dose angiostatic tyrosine kinase inhibitors improve photodynamic therapy for cancer: lack of vascular normalization" @default.
• Q37638911 P2093 "Andrea Weiss" @default.
• Q37638911 P2093 "Debora Bonvin" @default.
• Q37638911 P2093 "Patrice Jichlinski" @default.

• next